Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients

• Joanna Szkandera,

  Affiliations Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria, Research Unit Genetic Epidemiology and Pharmacogenetics, Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Armin Gerger,

  Affiliations Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria, Research Unit Genetic Epidemiology and Pharmacogenetics, Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Bernadette Liegl-Atzwanger,

  Affiliation Institute of Pathology, Medical University of Graz, Graz, Austria

  ⨯
• Michael Stotz,

  Affiliations Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria, Research Unit Genetic Epidemiology and Pharmacogenetics, Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Hellmut Samonigg,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Ferdinand Ploner,

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯
• Tatjana Stojakovic,

  Affiliation Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria

  ⨯
• Andreas Leithner,

  Affiliation Department of Orthopaedic Surgery, Medical University of Graz, Graz, Austria

  ⨯
• Martin Pichler

  * E-mail: martin.pichler@medunigraz.at

  Affiliation Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria

  ⨯